top of page

News
Search


TestAVec at BSGCT 2025.
The annual conference for the BSGCT is coming up, on 20th June at Royal Holloway, University of London. TestAVec's principle scientific...
12 minutes ago


TestAVec CSO Files patent for the manufacture of a pure viral vector.
Professor Mike Themis of Brunel University London – is the holder of a number of patents relating to gene therapy safety, safety testing...
3 days ago


Contaminating sequences found in gene therapy vectors
TestAVec researchers have identified contaminating sequences within HIV-1 viruses used for gene therapy. Researchers from Brunel...
Feb 27


First in vivo CAR-T gene therapy dosed
The first patient dosed with in vivo CAR-T gene therapy has now taken place. Interius BioTherapeutics have announced the first use of in...
Nov 4, 2024


Cancer causing risk of gene therapy in ALD treatment identified
Further incidences of insertional mutagenesis related cancer have been identified in patients treated for cerebral adrenoleukodystrophy...
Oct 30, 2024
bottom of page